Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry.

Christopher T SciriaThomas M MaddoxLucas MarzecBenjamin RodwinSalim S ViraniAmarnath AnnapureddyJames V FreemanAli O'HareYuyin LiuYang SongGheorghe DorosYue ZhengJane J LeeRamesh DaggubatiLina VadlamaniChristopher P CannonNihar R Desai

Published in: Clinical cardiology (2020)

Among AF patients treated with warfarin between October 1, 2010 and May 1, 2016, one in six were switched to DOACs, with differences across sociodemographic/clinical characteristics and substantial practice-level variation. In the context of current guidelines which favor DOACs over warfarin, these findings help benchmark performance and identify areas of improvement.

Keyphrases

direct oral anticoagulants
atrial fibrillation
venous thromboembolism
oral anticoagulants
left atrial
catheter ablation
left atrial appendage
heart failure
primary care
percutaneous coronary intervention
clinical practice
left ventricular
quality improvement